Resorcinol

Resorcinol

SCHEMBL4241256

C=O.NC(N)=O.Oc1cccc(O)c1

nearest known ligand 0.63

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.63
CA12 O43570 3/20 0.63
CA2 P00918 3/20 0.63
CA9 Q16790 3/20 0.63
CYP3A4 P08684 3/20 0.63
CA14 Q9ULX7 2/20 0.63
LMNA P02545 1/20 0.63
CA5A P35218 1/20 0.63
HSD17B10 Q99714 1/20 0.63
CA5B Q9Y2D0 1/20 0.63
PARP1 P09874 1/20 0.60
CA1 P00915 2/20 0.50
CA7 P43166 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
CA6 P23280 1/20 0.50
KDM4E B2RXH2 2/20 0.48
EGLN2 Q96KS0 1/20 0.45
ENPP2 Q13822 1/20 0.44
TSHR P16473 2/20 0.44
CYP2C9 P11712 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resorcinol SCHEMBL28241683 1.00 ALDH1A1 (0.63) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL6356882 0.95 ALDH1A1 (0.71) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL10857497 0.95 ALDH1A1 (0.71) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL958581 0.93 CA12 (0.55) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL27958075 0.89 ALDH1A1 (0.50) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL138369 0.89 CA12 (0.80) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL27982190 0.89 CA12 (0.80) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL28118320 0.87 ALDH1A1 (0.60) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL14976830 0.87 PARP1 (0.48) ALDH1A1CA12CA2CA9CYP3A4
Resorcinol SCHEMBL27758291 0.86 CA12 (0.67) ALDH1A1CA12CA2CA9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023244137-A1 MICROCAPSULAR FIRE-EXTINGUISHING AGENT ВИЛЕСОВ, Александр Дмитриевич 2023-12-21 WO claimed
US-20230086996-A1 Binder Compositions and Composite GEORGIA-PACIFIC CHEMICALS LLC (US) 2023-03-23 US claimed
WO-2021148964-A1 BINDER COMPOSITIONS AND COMPOSITE GEORGIA-PACIFIC CHEMICALS LLC (US) 2021-07-29 WO claimed
US-10907054-B2 Microcapsules having dual reagents separated by the capsule wall and methods for making same MICROTEK LABORATORIES, INC. (US) 2021-02-02 US claimed
CN-109475834-B Capsule with surfactant-tethered shell and method of making same 微技术实验室公司 2020-08-07 CN claimed
US-20200146378-A1 MOISTURE WICKING AND COOLING CAPSULES HAVING AN OUTER SHELL COMPRISING A SILOXANE AND METHODS FOR MAKING SAME MICROTEK LABORATORIES, INC. (US) 2020-05-14 US claimed
US-10561182-B2 Moisture wicking and cooling capsules having an outer shell comprising a siloxane and methods for making same MICROTEK LABORATORIES, INC. (US) 2020-02-18 US claimed
US-10335758-B2 Microcapsules having dual reagents for forming a self-healing material separated by the capsule wall and methods for making same MICROTEK LABORATORIES, INC. (US) 2019-07-02 US claimed
US-10316199-B2 Capsules having surfactant tethered outer shells and methods for making same MICROTEK LABORATORIES INC. (US) 2019-06-11 US claimed
US-20190161626-A1 MICROCAPSULES HAVING DUAL REAGENTS SEPARATED BY THE CAPSULE WALL AND METHODS FOR MAKING SAME MICROTEK LABORATORIES, INC. (US) 2019-05-30 US claimed
US-6765047-B2 HAVING A CORE/SHELL STRUCTURE WHEREIN CORE CONTAINS RED PHOSPHORUS IN PARTICULATE FORM AND WHEREIN SHELL CONTAINS UREA FORMALDEHYDE RESIN AND SILICON DIOXIDE BAYER AKTIENGESELLSCHAFT (DE) 2004-07-20 US claimed
US-20020188049-A1 Microencapsulation of red phosphorus LANXESS DEUTSCHLAND GMBH (DE) 2002-12-12 US claimed
US-5923412-A Encapsulated liquid toner printing apparatus HEWLETT-PACKARD COMPANY (US) 1999-07-13 US claimed
EP-0556844-B1 Flame retardant organosilicon polymer composition, process for making same, and article produced therefrom HERCULES INC (US) 1998-01-21 EP claimed
US-5558933-A FIBER BOARD COMPRISING CELLULOSE FIBERS AND A THERMOSETTING RESIN BONDED BY HEATING AND COMPRESSION ACI INTERNATIONAL LIMITED (AU) 1996-09-24 US claimed
US-5466512-A Flame retardant organosilicon polymer composition, process for making same, and article produced therefrom HERCULES INCORPORATED (US) 1995-11-14 US claimed
US-5298536-A Residues of one silicon-containing compound and at least one polycylic polyene compound linked through carbon-silicon bond HERCULES INCORPORATED (US) 1994-03-29 US claimed
EP-0556844-A2 Flame retardant organosilicon polymer composition, process for making same, and article produced therefrom HERCULES INCORPORATED (US) 1993-08-25 EP claimed
EP-0063475-B1 MICROENCAPSULATED EPOXY ADHESIVE SYSTEM CAPSULATED SYSTEMS, INC. (US) 1986-07-30 EP claimed
EP-0063475-A1 Microencapsulated epoxy adhesive system CAPSULATED SYSTEMS, INC. (US) 1982-10-27 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10907054-B2 Microcapsules having dual reagents separated by the capsule wall and methods for making same PHOSPHO1, MLEC, SGMS2 ALDH1A1 4367/4885CA12 612/4885CA2 2517/4885
US-20190161626-A1 MICROCAPSULES HAVING DUAL REAGENTS SEPARATED BY THE CAPSULE WALL AND METHODS FOR MAKING SAME PHOSPHO1, MLEC, SGMS2 ALDH1A1 4367/4885CA12 612/4885CA2 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.